Decision-making for Infants with Complex Life-Threatening Conditions

患有复杂的危及生命状况的婴儿的决策

基本信息

  • 批准号:
    8330667
  • 负责人:
  • 金额:
    $ 38.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-30 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Decision-Making For Infants with Complex Life-Threatening Conditions Abstract Infants with life-threatening conditions who earlier would have died in the first months of life are now receiving highly complex and sometimes experimental treatments designed to cure the condition or prolong life. However, these treatments have uncertain outcomes, the infants are at high risk for death, and if they live face a life-span of significant morbidity. Infants with these conditions experience an uncertain trajectory that typically involves multiple health crises requiring parents and health care providers to make critical decisions about the type and level of treatment. Decisions span the continuum from whether to initiate treatment, how to alter the treatment to respond to a medical crisis, whether to shift from aggressive curative care to symptom- focused palliative care, to whether to withdraw treatment. This 5-year study will use a longitudinal, case study design to examine the trajectory of decision making for infants undergoing life-sustaining treatment for complex life-threatening conditions (CLTC). Three groups of infants with CLTCs who are at particularly high risk for death and significant life-span morbidity are the focus of this study: extremely preterm infants (<26 weeks gestation), infants with complex cardiac anomalies, and infants with genetic diagnoses requiring a hematopoietic stem cell transplant (HSCT). Forty cases will be studied and each case will include the infant, parents, providers and the physical context of caregiving. Narrative interviews and self-report measures will be used with case members following birth or diagnosis and at least monthly thereafter until death or 1 year following enrollment. A within-case and cross-case analysis will be used to explore the trajectory of decision making for these infants and examine how and when decisions are across the illness trajectory. The study will identify transition points across the trajectory and identify factors influencing decision making, such as the level of involvement that parents' want; characteristics of parents who desire more or less involvement; and roles health care providers can play in decision making. The findings will be used to develop typologies of decision making and illness trajectory transition points for infants with CLTCs. These will provide a foundation for developing interventions to facilitate the decision making for these infants. PUBLIC HEALTH RELEVANCE: This study will use a longitudinal multiple case study design to examine the trajectory of decision making for infants with complex life-threatening conditions (CLTC) and influences on parents' decision making from birth or diagnosis until death or 12 months. This study will be the first study to prospectively examine the trajectory of all types of health-related decisions (treatment initiation and intensification, shifts in treatment from curative care to palliative care, withholding or withdrawing treatment) across a year-long illness trajectory, in multiple populations of infants with CLTCs, both those who die and those who survive. In addition, the sample of extremely premature infants (<26 weeks gestation), infants with complex congenital heart disease (CHD), and infants with genetic diagnoses requiring a hematopoietic stem cell transplant (HSCT) will allow for exploration of how decision making is both similar and different for infants undergoing experimental treatment for the three most common causes of pediatric death. We will identify transition points across the trajectory of decision making and identify the influences on decision making, such as the level of involvement that parents' want; characteristics of parents who desire more or less involvement; and roles health care providers play in decision making. The goal will be to identify transition points across the trajectory and provide a foundation for developing interventions to facilitate parents' decision-making for these infants.
描述(由申请人提供):针对患有复杂的危及生命状况的婴儿的决策摘要患有危及生命状况的婴儿在生命的最初几个月内可能会死亡,现在正在接受高度复杂的、有时是实验性的治疗,旨在治愈病情或延长生命。然而,这些治疗的结果不确定,婴儿死亡的风险很高,而且如果他们活着,也将面临显着的发病率。患有这些疾病的婴儿会经历一个不确定的轨迹,通常会涉及多种健康危机,需要父母和医疗保健提供者就治疗类型和水平做出关键决定。决策涵盖从是否开始治疗、如何改变治疗以应对医疗危机、是否从积极的治疗转向以症状为中心的姑息治疗,以及是否撤回治疗等一系列连续过程。这项为期 5 年的研究将采用纵向案例研究设计来检查因复杂危及生命的病症 (CLTC) 接受生命维持治疗的婴儿的决策轨迹。本研究的重点是三组患有 CLTC 的婴儿,这些婴儿死亡风险特别高,并且终生发病率显着升高:极早产儿(妊娠 <26 周)、患有复杂心脏异常的婴儿以及患有需要造血干细胞移植 (HSCT) 的基因诊断的婴儿。将研究四十个案例,每个案例都将包括婴儿、父母、提供者和护理的实际环境。病例成员出生或诊断后,至少每月一次,直至死亡或入组后一年,将采用叙述性访谈和自我报告措施。将使用病例内和跨病例分析来探索这些婴儿的决策轨迹,并检查决策如何以及何时跨越疾病轨迹。该研究将确定整个轨迹的转变点,并确定影响决策的因素,例如父母希望的参与程度;渴望或多或少参与的父母的特征;以及医疗保健提供者在决策中可以发挥的作用。研究结果将用于开发 CLTC 婴儿的决策类型和疾病轨迹转变点。这些将为制定干预措施奠定基础,以促进这些婴儿的决策。公共健康相关性:本研究将采用纵向多案例研究设计来研究患有复杂危及生命状况的婴儿 (CLTC) 的决策轨迹,以及从出生或诊断到死亡或 12 个月对父母决策的影响。这项研究将是第一项前瞻性研究多个 CLTC 婴儿群体(包括死亡婴儿和存活婴儿)在一年的疾病轨迹中所有类型的健康相关决策(治疗开始和强化、治疗从治疗护理转向姑息治疗、暂停或撤回治疗)轨迹的研究。此外,极早产儿(妊娠<26周)、患有复杂先天性心脏病(CHD)的婴儿以及基因诊断需要造血干细胞移植(HSCT)的婴儿的样本将有助于探索针对三种最常见的儿科死亡原因接受实验性治疗的婴儿的决策有何相似和不同。我们将确定决策轨迹上的转变点,并确定对决策的影响,例如父母希望的参与程度;渴望或多或少参与的父母的特征;以及医疗保健提供者在决策中发挥的作用。目标是确定整个轨迹的过渡点,并为制定干预措施奠定基础,以促进父母为这些婴儿做出决策。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Exploring the vagueness of Religion & Spirituality in complex pediatric decision-making: a qualitative study.
探索宗教的模糊性
  • DOI:
    10.1186/s12904-018-0360-y
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Superdock,AlexandraK;Barfield,RaymondC;Brandon,DebraH;Docherty,SharronL
  • 通讯作者:
    Docherty,SharronL
Crossroads of parental decision making: Intersections of hope, communication, relationships, and emotions.
父母决策的十字路口:希望、沟通、关系和情感的交叉点。
Communication about life-sustaining therapy: insights from the Adaptive Leadership Framework.
Challenges and coping between parents in shared decision-making for children with complex, life-threatening conditions: A qualitative content analysis.
父母在为患有复杂、危及生命的情况的儿童共同决策时面临的挑战和应对:定性内容分析。
  • DOI:
    10.1016/j.pedn.2023.07.018
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Son,Heeyeon;Oyesanya,ToluO;Brandon,Debra;Docherty,SharronL
  • 通讯作者:
    Docherty,SharronL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharron L Docherty其他文献

Sharron L Docherty的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharron L Docherty', 18)}}的其他基金

Peer i-Coaching for Activated Self-management Optimization in Adolescents and Young Adults with Chronic Conditions
同伴网络辅导可促进患有慢性病的青少年和年轻人的主动自我管理优化
  • 批准号:
    10573216
  • 财政年份:
    2019
  • 资助金额:
    $ 38.22万
  • 项目类别:
Peer i-Coaching for Activated Self-management Optimization in Adolescents and Young Adults with Chronic Conditions
同伴在线辅导可促进患有慢性病的青少年和年轻人的主动自我管理优化
  • 批准号:
    9922359
  • 财政年份:
    2019
  • 资助金额:
    $ 38.22万
  • 项目类别:
Peer i-Coaching for Activated Self-management Optimization in Adolescents and Young Adults with Chronic Conditions
同伴在线辅导可促进患有慢性病的青少年和年轻人的主动自我管理优化
  • 批准号:
    10362624
  • 财政年份:
    2019
  • 资助金额:
    $ 38.22万
  • 项目类别:
Decision-making for Infants with Complex Life-Threatening Conditions
患有复杂的危及生命状况的婴儿的决策
  • 批准号:
    8011252
  • 财政年份:
    2010
  • 资助金额:
    $ 38.22万
  • 项目类别:
Decision-making for Infants with Complex Life-Threatening Conditions
患有复杂的危及生命状况的婴儿的决策
  • 批准号:
    7578582
  • 财政年份:
    2008
  • 资助金额:
    $ 38.22万
  • 项目类别:
Decision-making for Infants with Complex Life-Threatening Conditions
患有复杂的危及生命状况的婴儿的决策
  • 批准号:
    8120494
  • 财政年份:
    2008
  • 资助金额:
    $ 38.22万
  • 项目类别:
Decision-making for Infants with Complex Life-Threatening Conditions
患有复杂的危及生命状况的婴儿的决策
  • 批准号:
    7693758
  • 财政年份:
    2008
  • 资助金额:
    $ 38.22万
  • 项目类别:
Decision-making for Infants with Complex Life-Threatening Conditions
患有复杂的危及生命状况的婴儿的决策
  • 批准号:
    7916543
  • 财政年份:
    2008
  • 资助金额:
    $ 38.22万
  • 项目类别:
Parental Care of Children Post Stem Cell Transplant
干细胞移植后儿童的父母护理
  • 批准号:
    6805392
  • 财政年份:
    2004
  • 资助金额:
    $ 38.22万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 38.22万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 38.22万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 38.22万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 38.22万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了